Sycrest – New Option for Bipolar I Disorder

Sycrest – New option for bipolar I disorder

Filed under: bipolar treatment options

Lundbeck wish to announce that Sycrest (asenapine) which is approved for the treatment of moderate to severe manic episodes associated with bipolar I disorder (BD-I) in adults, has been added to the list of medicines available to patients under the GMS …
Read more on Irish Medical Times

Your Questions about Bipolar Disorder Answered

Filed under: bipolar treatment options

One such treatment option, SEROQUEL XR® (quetiapine fumarate), is a once-daily medication that is FDA approved to treat both the manic highs and depressive lows of bipolar disorder. For more information about bipolar disorder and SEROQUEL XR, visit …
Read more on Fenton Tri County Times